Welcome to the e-CCO Library!

P026: Characterisation of mucosal CD4+ T-cells in peripheral blood of healthy controls and paediatric inflammatory bowel disease patients
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Joosse*1, C. Menckeberg1, L. de Ruiter1, H. Raatgeep1, L. van Berkel1, F. Muskens2, R. Hendriks2, R. Hoogenboezem3, T. Cupedo3, L. de Ridder4, H. Escher4, S. Veenbergen1, J. Samsom1

Created: Friday, 22 February 2019, 9:49 AM
P026: Cost per Response/Remission analysis of biologic therapies availables in Argentina for the treatment of Bio-exposed patients with moderate-to-severe active Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Elgart, J.(1);Balderramo, S.(2);Calvi, G.(3);Kanevsky, D.(3);Sánchez Gonzalez, Y.(4)*;
Created: Friday, 14 July 2023, 10:48 AM
P026: Establishment of an in vitro system to evaluate the therapeutic effect of the investigational drug on ulcerative colitis using human colonic organoids
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Hibiya*1, K. Tsuchiya1, R. Nishimura1, T. Shirasaki1, S. Watanabe1, N. Katsukura1, T. Nakamura2, M. Watanabe1

Created: Friday, 22 February 2019, 9:41 AM
P026: Inflammatory bowel disease does not preclude the presence of environmental enteropathy in Zambian adults
Year: 2022
Source: ECCO'22
Authors: Hodges, P.(1);Mulenga, C.(2);Banda, R.(2);Kelly, P.(1);
Created: Friday, 11 February 2022, 3:52 PM
P026: Microbial Diversity is affected by Cognitive Behavioral and Mindfulness-Based Stress Reduction and accompanied by an Inflammatory Response in Patients with Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Ilan, K.(1);Motro, Y.(2);Nemirovsky, A.(2);Lerner, L.(3);Schwartz, D.(4);Goren, G.(5);Sergienko, R.(6);Greenberg, D.(7);Slonim-Nevo , V.(5);Sarid, O.(5);Friger, M.(6);Regev, S.(5);Odes, S..(8);Moran-Gilad , J.(9);Monsonego, A.(10);
Created: Wednesday, 2 June 2021, 4:12 PM
P026: The impact of trophic effects of multi strain probiotic preparation on paracellular permeability
Year: 2018
Source: ECCO '18 Vienna
Authors:

V. Petito1*, L. Laterza1, C. Graziani1, D. Lucchetti2, L. Lopetuso1, A. Sgambato2, F. Scaldaferri1, A. Gasbarrini1

Created: Thursday, 21 February 2019, 9:14 AM
P026: The role of fibrocytes in mesenteric Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kiernan M.G.*1, Sahebally S.M.1,2, Kiely P.A.1, Waldron D.2, Moloney M.3, Skelly M.3, Faul P.N.4, O'Leary D.P.2, Lowery A.J.1,2, Walsh L.G.1,2, Dunne C.P.1, Coffey J.C.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P027 Repertoire analysis of memory T-cell receptors in Japanese patients with inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Takeru, Y. Kakuta, Y. Izumiyama, R. Ichikawa, D. Okamoto, R. Moroi, M. Kuroha, Y. Kanazawa, Y. Kinouchi, A. Masamune

Created: Thursday, 30 January 2020, 10:12 AM
P027: Anorectal Motility Disorders in Inflammatory Bowel Disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Costache, R.(1)*;Dimitriu, A.(1,2);Les, A.(1);Gheorghe, C.(1,2);
Created: Friday, 14 July 2023, 10:48 AM
P027: Characterisation of human intestinal dendritic cells and macrophages through the lower gastrointestinal tract.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

D. Bernardo*, A. C. Marín, P. M. Linares, M. Jiménez, M. Chaparro, J. P. Gisbert

Created: Friday, 22 February 2019, 9:49 AM
P027: Comparing the immunological signatures of inflammatory diseases
Year: 2017
Source: ECCO '17 Barcelona
Authors:

McDonald E.*1, Wright P.1, Zangerle-Murray T.2, Jung J.1, Gaya D.3, Siebert S.1, McInnes I.1, Milling S.1

Created: Wednesday, 20 February 2019, 10:36 AM
P027: Effects of anti-TNF and anti-α4β7 drugs on circulating monocytes migratory capacity in inflammatory bowel disease
Year: 2022
Source: ECCO'22
Authors: Soleto, I.(1);Fernández-Tomé, S.(2);Mora-Gutiérrez, I.(3);Baldan-Martin, M.(1);Ramirez, C.(1);Santander, C.(1);Moreno-Monteagudo, J.A.(1);Casanova, M.J.(1);Casals, F.(1);Casabona, S.(1);Becerro, I.(1);Chaparro, M.(1);Bernardo, D.(4);Gisbert, J.P.(1);
Created: Friday, 11 February 2022, 3:52 PM
P027: Epithelial cells of patients with ulcerative colitis do not show an increased sensitivity after microbiota stimulation compared to non-IBD controls
Year: 2021
Source: ECCO'21 Virtual
Authors: Arnauts, K.(1,2);Lapierre, C.(1);Verstockt, B.(1,3);Verstockt, S.(1);Sudhakar, P.(1);Vermeire, S.(1,3);Verfaillie, C.(2);Sabino, J.(1,3);Ferrante, M.(1,3);
Created: Wednesday, 2 June 2021, 4:12 PM
P027: Machine learning approaches to identify prognosis indicators from microbiome data
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Madgwick*1,2, P. Sudhakar1,2,3, T. Korcsmáros1,2

Created: Friday, 22 February 2019, 9:41 AM
P027: Vitamin A modulates mucosal inflammation by augmenting Th1/Th17 differentiation in inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Rampal1*, M.N. Wari1, A.K. Singh1, U.K. Das1, S. Bopanna1, S. Jain1, V. Gupta1, T. Velpandian2, S. Kedia3, D. Kumar4, A. Awasthi5, V. Ahuja1

Created: Thursday, 21 February 2019, 9:14 AM
P028 The anti-inflammatory effects of a poly-probiotic on the oral mucosa
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Marlina1, B. Hirani2, V. Mercadante1, M. Shephard3, S. Kishida4, G. Sebepos-Rogers5, R. McMillan3, T. Hodgson3, R. Leeson1, S. Porter1, J. Barber6, S. Fedele1, A. Smith1

Created: Thursday, 30 January 2020, 10:12 AM
P028: A distinct cellular signature of inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. McDonald1*, P. Wright1, T. Zangerle-Murray2, A. Bravo-Blas1, J. Jung1, E. Robertson3,4, S. Siebert1, D. McCarey4, D. Gaya4, D. Burden5, A. McEntegart4, I. McInnes1, S. Milling1

Created: Thursday, 21 February 2019, 9:14 AM
P028: Inflammatory bowel disease is associated with cytoskeleton rearrangement in the epithelial cells
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Portyanko1, P. Perevoschikov1, K. Ruksha1, J. Gorgun*2

Created: Friday, 22 February 2019, 9:49 AM
P028: Inhibition of stromal glycolysis by targeting PFKFB3 decreases experimental colitis
Year: 2022
Source: ECCO'22
Authors: Zhou, Z.(1);Plug, L.G.(1);de Jonge-Muller, E.S.M.(1);Abou Elmagd , A.(1);van der Meulen-de Jong, A.E.(1);Barnhoorn , M.C.(1);Hawinkels, L.J.A.C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P028: Oligonol attenuates dextran sulfate sodium-induced colitis and reduces flare-UP in mice by enhancing host defense mechanism
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kim K.-J.*1, Park J.-M.2, Han Y.-M.2, Lee S.G.2, Shin S.A.2, Hahm K.-B.2

Created: Wednesday, 20 February 2019, 10:36 AM